• 2662 Citations
  • 31 h-Index
20102019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Tumors Chemical Compounds
Small Interfering RNA Medicine & Life Sciences
Cells Chemical Compounds
Growth Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition

Ma, S., Pradeep, S., Villar-Prados, A., Wen, Y., Bayraktar, E., Mangala, L. S., Kim, M. S., Wu, S., Hu, W., Rodriguez-Aguayo, C., Leuschner, C., Liang, X., Ram, P., Schlacher, K., Coleman, R. & Sood, A. K., May 1 2019, In : Molecular cancer therapeutics. 18, 5, p. 969-979 11 p.

Research output: Contribution to journalArticle

Gonadotropin-Releasing Hormone
Ovarian Neoplasms
Peptides
Protein Array Analysis
Comet Assay

Predicting novel therapies and targets: Regulation of Notch3 by the bromodomain protein Brd4

Villar-Prados, A., Wu, S., Court, K. A., Ma, S., LaFargue, C., Chowdhury, M. A., Engelhardt, M. I., Ivan, C., Ram, P., Wang, Y., Baggerly, K. A., Rodriguez-Aguayo, C., Lopez, G., Yang, S. M., Maloney, D. J., Yoshioka, M., Strovel, J. W., Roszik, J. & Sood, A. K., Feb 1 2019, In : Molecular cancer therapeutics. 18, 2, p. 421-436 16 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Small Interfering RNA
Therapeutics
Down-Regulation
Neoplasms

PRKRA/PACT expression promotes chemoresistance of mucinous ovarian cancer

Hisamatsu, T., McGuire, M., Wu, S., Rupaimoole, R., Pradeep, S., Bayraktar, E., Noh, K., Hu, W., Hansen, J. M., Lyons, Y. A., Gharpure, K. M., Nagaraja, A. S., Mangala, L. S., Mitamura, T., Rodriguez-Aguayo, C., Eun, Y. G., Rose, J., Bartholomeusz, G., Ivan, C., Lee, J-S. & 5 othersMatsuo, K., Frumovitz, M., Wong, K. K., Lopez, G. & Sood, A. K., Jan 1 2019, In : Molecular cancer therapeutics. 18, 1, p. 162-172 11 p.

Research output: Contribution to journalArticle

oxaliplatin
Ovarian Neoplasms
Small Interfering RNA
Platinum
Phosphotransferases

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

Rodriguez-Aguayo, C., Bayraktar, E., Ivan, C., Aslan, B., Mai, J., He, G., Mangala, L. S., Jiang, D., Nagaraja, A. S., Ozpolat, B., Chavez-Reyes, A., Ferrari, M., Mitra, R., Siddik, Z. H., Shen, H., Yang, X., Sood, A. K. & Lopez, G., Feb 1 2019, In : EBioMedicine. 40, p. 290-304 15 p.

Research output: Contribution to journalArticle

Dinoprostone
Cisplatin
Ovary
Carcinogenesis
Up-Regulation

The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research

The Extracellular RNA Communication Consortium, Apr 4 2019, In : Cell. 177, 2, p. 231-242 12 p.

Research output: Contribution to journalReview article

Open Access
RNA
Technology
Communication
Research
Biomarkers